Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 6—June 2024
Dispatch

Burkholderia semiarida as Cause of Recurrent Pulmonary Infection in Immunocompetent Patient, China

Dai Kuang1, Feng Liu1, Shen Tian1, Wei Liu, Anyang Li, Yujing Zhou, Huaping HuangComments to Author , and Qianfeng XiaComments to Author 
Author affiliations: NHC Key Laboratory of Tropical Disease Control, School of Tropical Medicine, Hainan Medical University, Haikou, China (D. Kuang, S. Tian, W. Liu, A. Li, Y. Zhou, Q. Xia); The First Affiliated Hospital of Hainan Medical University, Haikou (F. Liu, H. Huang)

Main Article

Figure

Computed tomography scans of the chest at different stages of disease in immunocompetent patient with recurrent pulmonary infection caused by Burkholderia semiarida, China. A) Infiltrative lesions in the right lung in August 2020; B) multiple infiltrative lesions in both lungs substantially resorbed in June 2021; C) multiple infiltrative lesions of both lungs, predominantly in the right lung, in February 2022; D) bronchiectasis with scattered multiple lesions in both lungs and increased exudative lesions in the right upper lung in May 2022; E) lesions in the right lung more resorbed than before and multiple emerging lesions in the left lung in August 2022; F) lesions in the left lung more absorbed than before, with multiple emerging foci in the right lung in March 2023.

Figure. Computed tomography scans of the chest at different stages of disease in immunocompetent patient with recurrent pulmonary infection caused by Burkholderia semiarida, China. A) Infiltrative lesions in the right lung in August 2020; B) multiple infiltrative lesions in both lungs substantially resorbed in June 2021; C) multiple infiltrative lesions of both lungs, predominantly in the right lung, in February 2022; D) bronchiectasis with scattered multiple lesions in both lungs and increased exudative lesions in the right upper lung in May 2022; E) lesions in the right lung more resorbed than before and multiple emerging lesions in the left lung in August 2022; F) lesions in the left lung more absorbed than before, with multiple emerging foci in the right lung in March 2023.

Main Article

1These authors contributed equally to this article and share first authorship.

Page created: April 08, 2024
Page updated: May 22, 2024
Page reviewed: May 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external